Farmers & Merchants Investments Inc’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2K Hold
260
﹤0.01% 1477
2026
Q1
$1.2K Hold
260
﹤0.01% 1424
2025
Q4
$1.3K Hold
260
﹤0.01% 1372
2025
Q3
$1.32K Hold
260
﹤0.01% 1395
2025
Q2
$1.12K Hold
260
﹤0.01% 1410
2025
Q1
$1.57K Hold
260
﹤0.01% 1296
2024
Q4
$1.03K Hold
260
﹤0.01% 1463
2024
Q3
$1.52K Hold
260
﹤0.01% 1322
2024
Q2
$1.12K Hold
260
﹤0.01% 1415
2024
Q1
$1.22K Hold
260
﹤0.01% 1363
2023
Q4
$1.28K Hold
260
﹤0.01% 1342
2023
Q3
$1.42K Sell
260
-16
-6% -$128 ﹤0.01% 1217
2023
Q2
$2.56K Hold
276
﹤0.01% 971
2023
Q1
$2.27K Hold
276
﹤0.01% 974
2022
Q4
$3.08K Hold
276
﹤0.01% 889
2022
Q3
$3K Buy
+276
New +$4.18K ﹤0.01% 878

Other funds holding MPT

Farmers & Merchants Investments Inc's MPT Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Medical Properties Trust (MPT) position steady in Q2 2026 at 260 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Farmers & Merchants Investments Inc first reported a position in MPT in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.08K in Q4 2022. 241 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Farmers & Merchants Investments Inc held 260 shares of Medical Properties Trust worth $1.2K as of Q2 2026.
  • Farmers & Merchants Investments Inc left its Medical Properties Trust share count unchanged in Q2 2026.
  • Medical Properties Trust made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1477 holding.
  • Farmers & Merchants Investments Inc first reported a position in Medical Properties Trust in Q3 2022 and has held it in 16 quarters since.
  • Farmers & Merchants Investments Inc's Medical Properties Trust position peaked at $3.08K in Q4 2022.
  • 241 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.